University of Birmingham researchers found that blocking the P2X7 receptor significantly reduced inflammation in live human brain-cell cultures and tissue obtained during neurosurgery. The target could support repurposing existing drugs for brain injury, Alzheimer’s, Parkinson’s, depression and psyc